Global  

Merck & Co.

American pharmaceutical company

Merck & Co.    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck is incorporated in New Jersey.

0
shares
ShareTweetSavePostSend
 

You Might Like


Merck to buy Austrian vaccine maker as it jumps into COVID-19 race

Merck & Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit..
Reuters - Published

Fears of surge in coronavirus death toll weigh on S&P, Nasdaq

The S&P 500 and Nasdaq indexes eased on Tuesday as scientists warned of an increase in U.S. coronavirus deaths if states lifted lockdowns too quickly, while healthcare stocks slumped after a sales..
Reuters - Published

S&P 500, Nasdaq retreat as pandemic damage mounts

The S&P 500 and Nasdaq erased early gains on Tuesday as a plunge in consumer confidence underlined the extent of the economic damage from the coronavirus pandemic, while healthcare stocks slumped after..
Reuters - Published

Novartis, Merck and Allergan join those raising U.S. drug prices for 2020

Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020,..
Reuters - Published

Ebola vaccine approved by FDA

ebola vaccine approved by fda
The U.S. Food and Drug Administration has for the first time approved a vaccine for the prevention of the deadly Ebola virus disease. The agency announced the approval of Ervebo, a single-dose,..
WorldNews - Published

Merck receives FDA approval for Ebola vaccine

The U.S. Food and Drug Administration said on Thursday it approved drugmaker Merck & Co's Ebola vaccine Ervebo, making it the first FDA-authorised vaccine against the deadly virus.
Reuters - Published

Global stocks falter, dollar slips on potential U.S.-China trade delay

Global stocks faltered on Tuesday as strong earnings from U.S. drugmakers Merck and Pfizer and expectations the Federal Reserve will cut rates was offset by a potential delay in a U.S.-China trade..
Reuters - Published

World stocks edge higher on robust U.S. results, rate hopes; oil pares losses

World stocks edged higher on Tuesday, lifted by strong earnings from big U.S. drugmakers Merck and Pfizer and expectations of another dose of policy stimulus from the U.S. Federal Reserve, while oil..
Reuters - Published

S&P 500 hits record high on robust Merck, Pfizer earnings

The S&P 500 touched a record high on Tuesday as investors cheered strong earnings from big drugmakers Merck and Pfizer, while a disappointing profit from Google parent Alphabet kept the Nasdaq firmly..
Reuters - Published

Merck, Pfizer spur S&P 500 to record high; Alphabet weighs on Nasdaq

The S&P 500 hit a fresh record high on Tuesday, lifted by upbeat earnings from drugmakers Merck and Pfizer, while disappointing quarterly profit from Google-parent Alphabet kept the Nasdaq firmly in..
Reuters - Published

S&P 500 flat on mixed earnings reports; Alphabet weighs on Nasdaq

The S&P 500 hovered near its record high on Tuesday, lifted by upbeat earnings from drugmakers Merck and Pfizer, while a disappointing quarterly profit from Google-parent Alphabet kept the Nasdaq..
Reuters - Published

Wall Street dips at open after mixed earnings reports

Wall Street opened slightly lower on Tuesday as investors assessed a mixed batch of earnings reports, including from Google-parent Alphabet and big drugmakers Merck and Pfizer.
Reuters - Published

Merck’s Ebola vaccine is approved, which the WHO calls a ‘triumph’

merck’s ebola vaccine is approved, which the who calls a ‘triumph’
London — The world’s first Ebola vaccine was recommended for approval by European drugs regulators on Friday in a move hailed by the World Health Organisation (WHO) as a “triumph for public..
WorldNews - Published

Apple and Microsoft push Wall Street higher as trade worries abate

U.S. stocks climbed on Monday, helped by gains in Apple, Microsoft and Merck & Co, as investors set aside worries about the U.S.-China trade war.
Reuters - Published

Wall Street ends higher on back of buoyant Apple, Microsoft

U.S. stocks rose on Monday, helped by gains in Apple, Microsoft and Merck & Co as investors set aside worries about the U.S.-China trade war.
Reuters - Published

Congo ready for 2nd vaccine against Ebola

congo ready for 2nd vaccine against ebola
LONDON -- The World Health Organization on Monday announced Congo will start using a second experimental Ebola vaccine, as efforts to stop the deadly outbreak are stalled and Doctors Without Borders..
WorldNews - Published

Reuters asks judge to release secret Propecia documents

Reuters asked a U.S. judge on Thursday to unseal documents filed in court regarding potential risks associated with Propecia, Merck & Co's popular baldness drug.
Reuters - Published

Special Report: Court let Merck hide secrets about baldness drug's risks

By the time Kelly Pfaff got home from driving her son to school that morning, it was too late.
Reuters - Published

Technology stocks drag the market lower in early trading

technology stocks drag the market lower in early trading
NEW YORK (AP) — U.S. stocks moved broadly lower in morning trading Tuesday as investors again back away from technology companies. The tech sector led the losses in the S&P 500 for a second straight..
WorldNews - Published

Congo has given over 200,000 people Merck Ebola vaccine-gov't

congo has given over 200,000 people merck ebola vaccine-gov't
Congolese authorities and health workers vaccinated more than 200,000 people against Ebola in August, the government said on Sunday, using a Merck vaccine they hope will help rein in the world's second..
WorldNews - Published

Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat

cancer drug keytruda, vaccines propel merck to quarterly profit beat
Merck & Co Inc reported higher-than-expected second-quarter profit and revenue and raised its full-year earnings forecast on Tuesday, powered by strong demand for its blockbuster cancer immunotherapy..
WorldNews - Published

A teeny-tiny arm implant could, one day, prevent HIV for a full year

An implant device has the potential to administer a drug to prevent HIV for up to a year according to early trials from Merck.
USATODAY.com - Published